Long-term Safety Check for Eye Injection Treatment in Macular Degeneration

This is a follow-up study for people who have already been treated with EXG102-031, an experimental eye injection for wet age-related macular degeneration (a condition that affects central vision in older adults). Researchers want to monitor how safe and how well this medication continues to work over the long term—up to 5 years after you received the injection. You would visit the clinic regularly so doctors can check your vision and watch for any side effects.

While early results of this medication may be promising, doctors need to understand whether the treatment remains safe and effective over many years. This long-term follow-up helps ensure that people who received the injection continue to benefit from it without unexpected problems developing down the road.